From evidence to conclusions in psychiatric research

Canadian Journal of Psychiatry

Volumn 41, Issue 4, 1996, Pages 227-232

  Bilsker, Dan ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

conclusions; critical appraisal; evidence based

Indexed keywords

ARTICLE; PSYCHIATRY; RESEARCH; SCIENCE;

EID: 0029941659     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379604100407     Document Type: Article

References (19)

1. Evidence-Based Medicine Working Group. Evidence-based medicine. JAMA 1992;268:2420-5.
2. Goldner EM, Bilsker D. Evidence-based psychiatry. Can J Psychiatry 1995;40:97-101.
3. Streiner DL, Norman GR, Blum HM. PDQ epidemiology. Toronto: BC Decker Inc; 1989. 128 p.
4. Popper K. Science: conjectures and refutations. In: Klemke ED, Hollinger R, Kline AD, editors. Introductory readings in the philosophy of science. Buffalo: Prometheus Books; 1988. p 19-34.
5. Bechtel W. Philosophy of science. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. 136 p.
6. Peuskens J (Risperidone Study Group). Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 1995;166:712-26.
7. Seligman M. The effectiveness of psychotherapy. Am Psychol 1995;50:965-74.
8. Buchsbaum MS, Haier RJ. Psychopathology: biological approaches. Annu Rev Psychol 1983;34:401-30.
9. Copolov DL, Rubin RT, Stuart GW, Poland RE, Mander AJ, Sashidharan SP, Whitehouse AM, Blackburn IM, Freeman CP, Blackwood DHR. Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses. Biol Psychiatry 1989;25:879-93.
10. Grove WM, Andreasen NC. Simultaneous tests of many hypotheses in exploratory research. J Nerv Ment Dis 1982;170:3-8.
11. Randolph C, Goldberg TE, Weinberger DR. The neuropsychology of schizophrenia. In: Heilman KM, Valenstein E, editors. Clinical neuropsychology. 3rd ed. New York: Oxford University Press; 1993. p 499-522.
12. Sykes JB, editor. The Concise Oxford Dictionary. 7th ed. Oxford: The Clarendon Press; 1986.
13. Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, Smith M. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry 1995;152:191-6.
14. Marcolin MA, Davis JM. Platelet monoamine oxidase in schizophrenia: a meta-analysis. Schizophr Res 1992;7:249-67.
15. Borison RL, Pathiraja AP, Diamond BI, Meibach RC. Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacol Bull 1992;28:213-8.
16. Streiner DL. Sample size and power in psychiatric research. Can J Psychiatry 1990;35:616-20.
17. Robbins M. Experiences of schizophrenia. New York: The Guilford Press; 1993. 511 p.
18. Coplan JD, Liebowitz MR, Gorman JM, Fyer A, and others. Noradrenergic function in panic disorder: effects of intravenous clonidine pretreatment on lactate induced panic. Biol Psychiatry 1992;31:135-46.
19. Clark DM. Cognitive mediation of panic attacks induced by biological challenge tests. Advances in Behaviour Research & Therapy 1993;15:75-84.